Mymetics Corp (MYMX)

[bow-tie]

Specia - MDPI
www.mdpi.com › journal › processes
Prof. Dr. Florian M. Wurm Swiss Federal Institute of Technology Lausanne, Route Cantonale, 1015 Lausanne, Switzerland [e-mail] Dr. Martin Jordan Merck Biopharma, Biotech Process Sciences, Corsier-sur-Vevey, Switzerland [e-mail] Deadline for manuscript submissions: closed (30 April 2019) Message from the Guest Editors

essage from the Guest Editors
This Special Issue of “Transient Gene Expression for Rapid
Protein and Virus-Vector supply” focuses on protein
production and on the generation of innovative virus
vectors for the widest range of applications in R&D and for
potential use in the clinic.
We encourage submissions of papers that present various
technologies, used with CHO, HEK-293, HeLa and other
mammalian or non-mammalian derived cell lines
providing access to rapid protein synthesis and to virus
vectors. The papers should emphasize readily applicable
methods, both for “standard” laboratories, but also for
more specialized use at scales of operation that exceed the
typical research laboratory (“large scale transient gene
expression”). In spite of the fact that virus-mediated
transfer of genetic information can be considered
transient, such as with the help of Baculovirus vectors, the
editors of this Special Issue wish to restrict the issue to
submissions of “naked” DNA or RNA as carriers the genes of
interests into the host cell system

rof. Dr. Florian M. Wurm
Swiss Federal Institute of
Technology Lausanne, Route
Cantonale, 1015 Lausanne,
Switzerland
[e-mail]
Dr. Martin Jordan Merck Biopharma, Biotech
Process Sciences, Corsier-surVevey, Switzerland
[e-mail]
Deadline for manuscript
submissions:
closed (30 April 2019)


Mario Amacker
Sylvain Fleury

Recombinant PfCyRPA expressed in HEK 293 cells was chemically coupled to phosphoethanolamine and then incorporated into the membrane of unadjuvanted influenza virosomes approved as antigen delivery system for humans
https://www.researchgate.net/publication/338945184_Vaccination_with_virosomally_formulated_recombinant_CyRPA_elicits_protective_antibodies_against_Plasmodium_falciparum_parasites_in_preclinical_in_vitro_and_in_vivo_models